Iovance Biotherapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.

About IOVA

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. 

CEO
Frederick G. Vogt
CEOFrederick G. Vogt
Employees
319
Employees319
Headquarters
San Carlos, California
HeadquartersSan Carlos, California
Founded
2007
Founded2007
Employees
319
Employees319

IOVA Key Statistics

Market cap
969.14M
Market cap969.14M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
4.36M
Average volume4.36M
High today
$6.18
High today$6.18
Low today
$6.16
Low today$6.16
Open price
$6.29
Open price$6.29
Volume
624.00
Volume624.00
52 Week high
$20.60
52 Week high$20.60
52 Week low
$5.42
52 Week low$5.42

IOVA News

Yahoo Finance 2h
Iovance Biotherapeutics to Present at Upcoming Conferences - Yahoo Finance

Iovance Biotherapeutics, Inc. SAN CARLOS, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology co...

Iovance Biotherapeutics to Present at Upcoming Conferences - Yahoo Finance

Analyst ratings

80%

of 15 ratings
Buy
80%
Hold
20%
Sell
0%

IOVA Earnings

-$0.64
-$0.43
-$0.21
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, After Hours
ActualExpected Feb 23, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.